In early tumorigenesis stages, TGF-β is suppressive; in the advanced stages, it promotes immune evasion, angiogenesis, and tumor metastasis, driving cancer progression (42, 43) (Figure 1). This evidence concerns the gene TGFB1 and neoplasm.